MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 63 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,938,323 | +7.7% | 1,621,118 | 0.0% | 46.52% | +3.3% |
| Q1 2023 | $38,939,254 | +23.2% | 1,621,118 | 0.0% | 45.05% | +22.2% |
| Q4 2022 | $31,611,801 | -21.7% | 1,621,118 | -15.6% | 36.87% | -21.3% |
| Q3 2022 | $40,363,000 | +8.0% | 1,921,118 | 0.0% | 46.86% | -14.7% |
| Q2 2022 | $37,385,000 | -11.6% | 1,921,118 | 0.0% | 54.94% | +26.5% |
| Q1 2022 | $42,303,000 | +38.1% | 1,921,118 | 0.0% | 43.42% | +98.6% |
| Q4 2021 | $30,642,000 | -19.9% | 1,921,118 | 0.0% | 21.86% | +240.2% |
| Q3 2021 | $38,269,000 | +15.2% | 1,921,118 | 0.0% | 6.42% | -1.0% |
| Q2 2021 | $33,216,000 | -12.8% | 1,921,118 | 0.0% | 6.49% | +10.7% |
| Q1 2021 | $38,077,000 | +13.5% | 1,921,118 | 0.0% | 5.86% | +59.1% |
| Q4 2020 | $33,543,000 | – | 1,921,118 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |